Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?
The Zacks Consensus Estimate for revenues is pegged at $3.50 billion, while the same for earnings is pinned at $0.56 per share.
Factors to Consider for VTRS Q2 Earnings
The company reports under four segments on the basis of geography — Developed Markets; Emerging Markets; Japan, Australia and New Zealand ('JANZ'); and Greater China.
Growth in Developed Markets, driven by brands such as Creon, Brufen, and its Thrombosis portfolio, has likely boosted sales from this segment and offset the decline in generics.
While sales from Europe have likely maintained growth, the same from North America have possibly been under pressure due to inspections in the manufacturing facility in Indore, India, and expected competition in the generic business.
The Zacks Consensus Estimate for revenues from Developed Markets is pinned at $2.1 billion.
Sales from Emerging Markets were under pressure in the first quarter due to the impact of the Indore facility and customer buying patterns on the generics business. Nonetheless, growth in brands across the cardiovascular portfolio in certain Latin American countries and continued strengths in the Middle East and North America and Eurasia regions have likely offset this impact in the second quarter.
The Zacks Consensus Estimate for revenues from this geography is pegged at $542 million.
Sales in JANZ are likely to have been adversely impacted by government-driven price regulations in Japan and Australia, as well as by a change in Japan's reimbursement for off-patent brands that accelerated generic conversion. The Zacks Consensus Estimate for revenues from the JANZ markets is pinned at $310 million.
Sales in Greater China might have seen an increase due to the company's diversified model across e-commerce, retail, and private hospitals.
The Zacks Consensus Estimate for revenues from this geography is pegged at $546 million.
Viatris also reports revenues under two divisions (in terms of product category) — brands and generics.
Brand business comprises the majority of the company's portfolio. Brand performance is likely to have benefited from the expansion of its cardiovascular portfolio in certain Latin American countries and strong growth in Europe and Greater China.
Operating expenses might have risen during the quarter due to SG&A investments in new product launches and progress in key R&D programs.
VTRS' Share Price Performance
Viatris' shares have lost 29.3% in the past year compared with the industry's decline of 8.4%.
Image Source: Zacks Investment Research
VTRS' Mixed Earnings Surprise History
The company's earnings beat estimates in three of the trailing four quarters and missed in the remaining one, delivering an average surprise of 2.14%. In the last reported quarter, VTRS beat on earnings by 2.04%.
Viatris Inc. Price, Consensus and EPS Surprise
Viatris Inc. price-consensus-eps-surprise-chart | Viatris Inc. Quote
What Our Model Predicts for Viatris
Our proven model does not conclusively predict an earnings beat for Viatris this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case here, as you will see below.
Earnings ESP: VTRS has an Earnings ESP of 0.0% as both the Zacks Consensus Estimate and the Most Accurate Estimate are pinned at 56 cents. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank #3.
Stocks to Consider
Here are some drug/biotech stocks that have the right combination of elements to beat on earnings this time around.
Amneal Pharmaceuticals (AMRX) has an Earnings ESP of +13.21% and a Zacks Rank #2 at present. You can see the complete list of today's Zacks #1 Rank stocks here.
Amneal beat on earnings in three of the trailing four quarters and missed in the remaining one, delivering an average surprise of 14.34%. AMRX is scheduled to report second-quarter results on Aug. 5.
Exact Sciences (EXAS) has an Earnings ESP of +475.00% and a Zacks Rank #2 at present.
Shares of EXAS have lost 16.4% year to date. It beat on earnings in three of the trailing four quarters and missed in the other one, delivering an average surprise of 48.79%. Exact Sciences is expected to report second-quarter results on Aug. 6, after market close.
Pfizer (PFE) has an Earnings ESP of +1.43% and a Zacks Rank #3 at present. The company is scheduled to release second-quarter results on Aug. 5. Higher sales of Pfizer's products like Vyndaqel family, Padcev, Lorbrena and Nurtec are expected to have offset softer sales of some key products like Prevnar, Xeljanz, Eliquis and Ibrance in the second quarter.
PFE beat on earnings in each of the trailing four quarters, delivering an average surprise of 43.49%.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Pfizer Inc. (PFE) : Free Stock Analysis Report
Exact Sciences Corporation (EXAS) : Free Stock Analysis Report
AMNEAL PHARMACEUTICALS, INC. (AMRX) : Free Stock Analysis Report
Viatris Inc. (VTRS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Is Travelzoo (TZOO) Stock Undervalued Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large. Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today. Travelzoo (TZOO) is a stock many investors are watching right now. TZOO is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock has a Forward P/E ratio of 8.9. This compares to its industry's average Forward P/E of 26.08. Over the past 52 weeks, TZOO's Forward P/E has been as high as 19.08 and as low as 8.24, with a median of 10.90. Finally, our model also underscores that TZOO has a P/CF ratio of 12.81. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. TZOO's current P/CF looks attractive when compared to its industry's average P/CF of 15.37. Within the past 12 months, TZOO's P/CF has been as high as 20.36 and as low as 7.45, with a median of 12.46. These are only a few of the key metrics included in Travelzoo's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, TZOO looks like an impressive value stock at the moment. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Travelzoo (TZOO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
an hour ago
- Yahoo
Inflation, Fed Leadership and Other Key Things to Watch this Week
Markets face a pivotal week as the S&P 500 ($SPX) (SPY) navigates mounting political pressure on Federal Reserve Chair Jerome Powell amid growing calls for more aggressive rate cuts following recent labor market weakening. President Trump has intensified criticism of Powell's cautious approach to monetary policy, while reports emerge that the administration has widened its search for Powell's potential successor, with former St. Louis Fed President James Bullard, National Economic Council director Kevin Hassett, and Fed Governor Christopher Waller among the names under consideration. Treasury Secretary Scott Bessent is reportedly leading the search process and conducting initial interviews, adding uncertainty to an already complex policy environment. The week delivers a comprehensive inflation assessment through Tuesday's Consumer Price Index and Thursday's Producer Price Index, while Friday's retail sales data will provide insights into consumer spending patterns that account for approximately two-thirds of GDP. Here are 5 things to watch this week in the Market. More News from Barchart 1 'Strong Buy' Defense Stock to Snag Instead of Palantir Is Qualcomm the Best Semiconductor Stock to Buy Right Now? A $10 Billion Reason to Buy Palantir Stock Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Fed Leadership Uncertainty and Policy Implications The Trump administration's expanded search for Powell's replacement creates uncertainty about monetary policy direction, potentially influencing market reactions to this week's economic data and corporate earnings. Reports that Treasury Secretary Scott Bessent is conducting initial interviews with candidates including James Bullard, Kevin Hassett, and Christopher Waller suggest the administration is serious about leadership change amid ongoing disagreements over rate policy. This political pressure comes as markets already grapple with mixed economic signals and questions about the appropriate pace of monetary policy adjustments. The uncertainty could impact bond markets, the dollar, and rate-sensitive sectors as investors attempt to gauge potential policy shifts under new leadership. Fed independence concerns may also influence how markets interpret upcoming inflation data, with any signs of political interference potentially affecting long-term credibility and market stability. Inflation Data Double-Header Tuesday's Consumer Price Index at 8:30am takes center stage as the week's most important economic release, providing insights into July inflation trends amid ongoing concerns about price pressures and Fed policy direction. Both headline and core CPI readings will be scrutinized for evidence of continued disinflation progress or potential re-acceleration in price growth. Thursday's Producer Price Index at 8:30am will offer a forward-looking perspective on wholesale price pressures and potential future consumer inflation trends. The timing of these reports amid Fed leadership uncertainty creates potential for amplified market reactions, particularly if inflation data contradicts current policy expectations or provides ammunition for either side of the rate cut debate. Energy prices, housing costs, and services inflation will be key components to watch, especially given recent volatility in commodity markets and ongoing labor market changes. Consumer Spending Reality Check Friday's July retail sales data at 8:30am represents a crucial test of consumer resilience, providing insights into spending patterns that drive the largest component of economic growth. With consumer spending accounting for roughly two-thirds of GDP, this report takes on heightened significance amid questions about economic momentum and the sustainability of recent growth trends. The data will be particularly important for assessing whether consumers are maintaining spending despite labor market weakening and ongoing inflation concerns. Core retail sales, which exclude volatile automotive purchases, will provide additional insight into underlying consumer demand trends. Thursday's initial jobless claims will complement the spending picture by offering the latest snapshot of labor market conditions, creating potential for significant market moves if employment and consumption data collectively suggest strengthening or weakening economic fundamentals. Technology and Global Earnings Focus Wednesday's Cisco (CSCO) earnings will provide crucial insights into enterprise technology spending and networking equipment demand amid ongoing questions about corporate IT investment priorities. The results will be closely watched for commentary on AI infrastructure spending, cloud migration trends, and the health of business technology budgets. Thursday brings a diverse international lineup with (JD) offering perspective on Chinese e-commerce trends, Applied Materials (AMAT) providing insights into semiconductor equipment demand, and Nu Holdings (NU) delivering Latin American fintech trends. Tuesday's Sea Limited (SE) earnings will offer perspective on Southeast Asian digital trends and gaming markets. These results will provide a global view of technology adoption and consumer behavior across key international markets. Energy and Commodity Market Dynamics Wednesday's crude oil inventories report at 10:30am will provide the latest snapshot of energy market conditions amid ongoing geopolitical uncertainties and seasonal demand patterns. The report comes as markets assess the impact of recent OPEC+ decisions and global economic growth concerns on oil demand and pricing. Energy sector earnings this week, including Thursday's Petrobras (PBR) results, will offer perspective on global oil and gas market conditions and production strategies. The intersection of energy prices with inflation data creates additional complexity, as commodity price movements could influence both CPI readings and Fed policy considerations. Energy companies' capital expenditure plans and production guidance will be closely watched for insights into supply dynamics and future price trends, particularly important given energy's role in both inflation calculations and broader economic sentiment. Best of luck this week and don't forget to check out my daily options article. On the date of publication, Gavin McMaster had a position in: SPY. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
2 hours ago
- Bloomberg
Hedge Funds Flip on Green Energy and Start Betting Against Oil
Portfolio managers have been reversing strategies that have dominated over the past four years. Hedge funds are betting against oil stocks and winding back shorts on solar in a reversal of positions that dominated their energy strategies over the past four years. Since the beginning of October and through the second quarter, equity-focused hedge funds have — on average — been mostly short oil stocks, according to a Bloomberg Green analysis of positions on companies in global indexes for sectors spanning oil, wind, solar and electric vehicles. That's a reversal of bets that had dominated since 2021, according to the data, which are based on fund disclosures to Hazeltree, an alternative-investment data specialist.
